nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—CYP2D6—Bicalutamide—prostate cancer	0.047	0.145	CbGbCtD
Bepridil—ABCB1—Estramustine—prostate cancer	0.0464	0.143	CbGbCtD
Bepridil—CYP2D6—Abiraterone—prostate cancer	0.0389	0.12	CbGbCtD
Bepridil—ABCB1—Cabazitaxel—prostate cancer	0.0306	0.0941	CbGbCtD
Bepridil—ABCB1—Estrone—prostate cancer	0.0299	0.092	CbGbCtD
Bepridil—ABCB1—Ethinyl Estradiol—prostate cancer	0.0266	0.082	CbGbCtD
Bepridil—ABCB1—Conjugated Estrogens—prostate cancer	0.0195	0.0602	CbGbCtD
Bepridil—ABCB1—Mitoxantrone—prostate cancer	0.0178	0.0547	CbGbCtD
Bepridil—ABCB1—Estradiol—prostate cancer	0.0172	0.0528	CbGbCtD
Bepridil—ABCB1—Prednisone—prostate cancer	0.0148	0.0454	CbGbCtD
Bepridil—ABCB1—Etoposide—prostate cancer	0.0112	0.0345	CbGbCtD
Bepridil—ABCB1—Docetaxel—prostate cancer	0.0103	0.0316	CbGbCtD
Bepridil—ABCB1—Doxorubicin—prostate cancer	0.00764	0.0235	CbGbCtD
Bepridil—CYP2D6—Doxorubicin—prostate cancer	0.0072	0.0222	CbGbCtD
Bepridil—CALM2—semen—prostate cancer	0.00628	0.0511	CbGeAlD
Bepridil—CALM1—semen—prostate cancer	0.00625	0.0509	CbGeAlD
Bepridil—PDE1B—prostate gland—prostate cancer	0.0048	0.0391	CbGeAlD
Bepridil—TNNC1—prostate gland—prostate cancer	0.0046	0.0374	CbGeAlD
Bepridil—PDE1A—prostate gland—prostate cancer	0.00402	0.0327	CbGeAlD
Bepridil—KCNQ1—prostate gland—prostate cancer	0.00374	0.0304	CbGeAlD
Bepridil—KCNQ1—seminal vesicle—prostate cancer	0.00316	0.0257	CbGeAlD
Bepridil—CACNA1H—prostate gland—prostate cancer	0.00314	0.0256	CbGeAlD
Bepridil—PDE1A—renal system—prostate cancer	0.00274	0.0223	CbGeAlD
Bepridil—CACNA1H—seminal vesicle—prostate cancer	0.00266	0.0216	CbGeAlD
Bepridil—CACNA1D—prostate gland—prostate cancer	0.00259	0.0211	CbGeAlD
Bepridil—KCNQ1—renal system—prostate cancer	0.00255	0.0207	CbGeAlD
Bepridil—Cyclizine—SULT1E1—prostate cancer	0.00253	0.503	CrCbGaD
Bepridil—KCNQ1—urethra—prostate cancer	0.0025	0.0204	CbGeAlD
Bepridil—CACNA1A—testis—prostate cancer	0.00242	0.0197	CbGeAlD
Bepridil—CYP2D6—urine—prostate cancer	0.00242	0.0197	CbGeAlD
Bepridil—CACNA1C—prostate gland—prostate cancer	0.00239	0.0195	CbGeAlD
Bepridil—PDE1B—testis—prostate cancer	0.00211	0.0172	CbGeAlD
Bepridil—TNNC1—testis—prostate cancer	0.00203	0.0165	CbGeAlD
Bepridil—CALM3—prostate gland—prostate cancer	0.002	0.0163	CbGeAlD
Bepridil—KCNQ1—bone marrow—prostate cancer	0.00193	0.0157	CbGeAlD
Bepridil—ATP1A1—prostate gland—prostate cancer	0.00179	0.0145	CbGeAlD
Bepridil—PDE1A—testis—prostate cancer	0.00177	0.0144	CbGeAlD
Bepridil—CACNA2D2—testis—prostate cancer	0.00171	0.0139	CbGeAlD
Bepridil—CALM3—seminal vesicle—prostate cancer	0.0017	0.0138	CbGeAlD
Bepridil—KCNQ1—testis—prostate cancer	0.00165	0.0134	CbGeAlD
Bepridil—CALM2—prostate gland—prostate cancer	0.00157	0.0128	CbGeAlD
Bepridil—CALM1—prostate gland—prostate cancer	0.00157	0.0127	CbGeAlD
Bepridil—PDE1B—lymph node—prostate cancer	0.00153	0.0125	CbGeAlD
Bepridil—ATP1A1—seminal vesicle—prostate cancer	0.00151	0.0123	CbGeAlD
Bepridil—TNNC1—lymph node—prostate cancer	0.00147	0.012	CbGeAlD
Bepridil—KCNH2—prostate gland—prostate cancer	0.00143	0.0116	CbGeAlD
Bepridil—CACNA1H—testis—prostate cancer	0.00138	0.0113	CbGeAlD
Bepridil—CALM3—urethra—prostate cancer	0.00134	0.0109	CbGeAlD
Bepridil—CALM2—seminal vesicle—prostate cancer	0.00133	0.0108	CbGeAlD
Bepridil—ATP1A1—epithelium—prostate cancer	0.00131	0.0107	CbGeAlD
Bepridil—PDE1A—lymph node—prostate cancer	0.00128	0.0105	CbGeAlD
Bepridil—CACNA2D2—lymph node—prostate cancer	0.00124	0.0101	CbGeAlD
Bepridil—ATP1A1—renal system—prostate cancer	0.00122	0.00991	CbGeAlD
Bepridil—KCNH2—seminal vesicle—prostate cancer	0.00121	0.00981	CbGeAlD
Bepridil—ATP1A1—urethra—prostate cancer	0.0012	0.00974	CbGeAlD
Bepridil—KCNQ1—lymph node—prostate cancer	0.00119	0.00972	CbGeAlD
Bepridil—CALM2—epithelium—prostate cancer	0.00116	0.00941	CbGeAlD
Bepridil—CALM1—epithelium—prostate cancer	0.00115	0.00937	CbGeAlD
Bepridil—CACNA1D—testis—prostate cancer	0.00114	0.00929	CbGeAlD
Bepridil—CALM2—renal system—prostate cancer	0.00107	0.00873	CbGeAlD
Bepridil—CALM1—renal system—prostate cancer	0.00107	0.00869	CbGeAlD
Bepridil—CACNA1C—testis—prostate cancer	0.00105	0.00858	CbGeAlD
Bepridil—CALM2—urethra—prostate cancer	0.00105	0.00857	CbGeAlD
Bepridil—CALM1—urethra—prostate cancer	0.00105	0.00853	CbGeAlD
Bepridil—CALM3—bone marrow—prostate cancer	0.00103	0.0084	CbGeAlD
Bepridil—CACNA1H—lymph node—prostate cancer	0.001	0.00816	CbGeAlD
Bepridil—KCNH2—renal system—prostate cancer	0.000972	0.00791	CbGeAlD
Bepridil—KCNH2—urethra—prostate cancer	0.000955	0.00777	CbGeAlD
Bepridil—ATP1A1—bone marrow—prostate cancer	0.000921	0.00749	CbGeAlD
Bepridil—CALM3—testis—prostate cancer	0.000883	0.00718	CbGeAlD
Bepridil—CACNA1D—lymph node—prostate cancer	0.000828	0.00673	CbGeAlD
Bepridil—CALM2—bone marrow—prostate cancer	0.000811	0.0066	CbGeAlD
Bepridil—CALM1—bone marrow—prostate cancer	0.000807	0.00657	CbGeAlD
Bepridil—ATP1A1—testis—prostate cancer	0.000787	0.00641	CbGeAlD
Bepridil—CACNA1C—lymph node—prostate cancer	0.000764	0.00622	CbGeAlD
Bepridil—KCNH2—bone marrow—prostate cancer	0.000735	0.00598	CbGeAlD
Bepridil—CALM2—testis—prostate cancer	0.000693	0.00564	CbGeAlD
Bepridil—CALM1—testis—prostate cancer	0.00069	0.00562	CbGeAlD
Bepridil—CALM3—lymph node—prostate cancer	0.00064	0.00521	CbGeAlD
Bepridil—KCNH2—testis—prostate cancer	0.000628	0.00511	CbGeAlD
Bepridil—ABCB1—prostate gland—prostate cancer	0.000625	0.00509	CbGeAlD
Bepridil—CYP2D6—renal system—prostate cancer	0.000593	0.00482	CbGeAlD
Bepridil—ATP1A1—lymph node—prostate cancer	0.000571	0.00464	CbGeAlD
Bepridil—ABCB1—seminal vesicle—prostate cancer	0.000529	0.0043	CbGeAlD
Bepridil—CALM2—lymph node—prostate cancer	0.000503	0.00409	CbGeAlD
Bepridil—CALM1—lymph node—prostate cancer	0.0005	0.00407	CbGeAlD
Bepridil—ABCB1—epithelium—prostate cancer	0.00046	0.00374	CbGeAlD
Bepridil—KCNH2—lymph node—prostate cancer	0.000455	0.0037	CbGeAlD
Bepridil—Phenoxybenzamine—SLC22A3—prostate cancer	0.000444	0.0883	CrCbGaD
Bepridil—ABCB1—renal system—prostate cancer	0.000426	0.00347	CbGeAlD
Bepridil—ABCB1—urethra—prostate cancer	0.000419	0.00341	CbGeAlD
Bepridil—CYP2D6—testis—prostate cancer	0.000383	0.00312	CbGeAlD
Bepridil—Diphenhydramine—CYP2C18—prostate cancer	0.000327	0.065	CrCbGaD
Bepridil—ABCB1—bone marrow—prostate cancer	0.000322	0.00262	CbGeAlD
Bepridil—Phenoxybenzamine—SLC22A1—prostate cancer	0.000318	0.0633	CrCbGaD
Bepridil—Fentanyl—CYP3A5—prostate cancer	0.000303	0.0603	CrCbGaD
Bepridil—ABCB1—testis—prostate cancer	0.000276	0.00224	CbGeAlD
Bepridil—Diphenhydramine—SLC22A1—prostate cancer	0.000267	0.0531	CrCbGaD
Bepridil—Cough—Etoposide—prostate cancer	0.000205	0.000795	CcSEcCtD
Bepridil—Somnolence—Mitoxantrone—prostate cancer	0.000205	0.000795	CcSEcCtD
Bepridil—Dizziness—Conjugated Estrogens—prostate cancer	0.000204	0.000793	CcSEcCtD
Bepridil—Phenoxybenzamine—ADRB2—prostate cancer	0.000203	0.0404	CrCbGaD
Bepridil—Dyspepsia—Mitoxantrone—prostate cancer	0.000203	0.000787	CcSEcCtD
Bepridil—Hypertension—Etoposide—prostate cancer	0.000203	0.000787	CcSEcCtD
Bepridil—Tinnitus—Capecitabine—prostate cancer	0.000202	0.000785	CcSEcCtD
Bepridil—Gastrointestinal pain—Estradiol—prostate cancer	0.000202	0.000785	CcSEcCtD
Bepridil—Liver function test abnormal—Epirubicin—prostate cancer	0.000202	0.000783	CcSEcCtD
Bepridil—Cardiac disorder—Capecitabine—prostate cancer	0.000201	0.000782	CcSEcCtD
Bepridil—Decreased appetite—Mitoxantrone—prostate cancer	0.0002	0.000777	CcSEcCtD
Bepridil—Arrhythmia—Docetaxel—prostate cancer	0.0002	0.000777	CcSEcCtD
Bepridil—ABCB1—lymph node—prostate cancer	0.0002	0.00162	CbGeAlD
Bepridil—Pain—Mitoxantrone—prostate cancer	0.000197	0.000764	CcSEcCtD
Bepridil—Constipation—Mitoxantrone—prostate cancer	0.000197	0.000764	CcSEcCtD
Bepridil—Bradycardia—Prednisone—prostate cancer	0.000197	0.000764	CcSEcCtD
Bepridil—Rash—Goserelin—prostate cancer	0.000197	0.000763	CcSEcCtD
Bepridil—Dermatitis—Goserelin—prostate cancer	0.000196	0.000762	CcSEcCtD
Bepridil—Abdominal pain—Estradiol—prostate cancer	0.000195	0.000758	CcSEcCtD
Bepridil—Body temperature increased—Estradiol—prostate cancer	0.000195	0.000758	CcSEcCtD
Bepridil—Headache—Goserelin—prostate cancer	0.000195	0.000758	CcSEcCtD
Bepridil—Rash—Conjugated Estrogens—prostate cancer	0.000195	0.000756	CcSEcCtD
Bepridil—Dermatitis—Conjugated Estrogens—prostate cancer	0.000194	0.000755	CcSEcCtD
Bepridil—Arrhythmia—Capecitabine—prostate cancer	0.000194	0.000752	CcSEcCtD
Bepridil—Headache—Conjugated Estrogens—prostate cancer	0.000193	0.000751	CcSEcCtD
Bepridil—Gastritis—Epirubicin—prostate cancer	0.000193	0.000751	CcSEcCtD
Bepridil—Influenza—Epirubicin—prostate cancer	0.000189	0.000733	CcSEcCtD
Bepridil—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000188	0.000731	CcSEcCtD
Bepridil—Liver function test abnormal—Doxorubicin—prostate cancer	0.000187	0.000724	CcSEcCtD
Bepridil—Flatulence—Capecitabine—prostate cancer	0.000186	0.000722	CcSEcCtD
Bepridil—Nausea—Goserelin—prostate cancer	0.000185	0.000719	CcSEcCtD
Bepridil—Hyperhidrosis—Etoposide—prostate cancer	0.000185	0.000719	CcSEcCtD
Bepridil—Angina pectoris—Epirubicin—prostate cancer	0.000184	0.000714	CcSEcCtD
Bepridil—Nausea—Conjugated Estrogens—prostate cancer	0.000183	0.000712	CcSEcCtD
Bepridil—Anorexia—Etoposide—prostate cancer	0.000183	0.000709	CcSEcCtD
Bepridil—Body temperature increased—Mitoxantrone—prostate cancer	0.000182	0.000707	CcSEcCtD
Bepridil—Abdominal pain—Mitoxantrone—prostate cancer	0.000182	0.000707	CcSEcCtD
Bepridil—Gastritis—Doxorubicin—prostate cancer	0.000179	0.000694	CcSEcCtD
Bepridil—Vision blurred—Capecitabine—prostate cancer	0.000178	0.000691	CcSEcCtD
Bepridil—Asthenia—Estradiol—prostate cancer	0.000177	0.000688	CcSEcCtD
Bepridil—Tremor—Capecitabine—prostate cancer	0.000177	0.000687	CcSEcCtD
Bepridil—Syncope—Docetaxel—prostate cancer	0.000175	0.000679	CcSEcCtD
Bepridil—Influenza—Doxorubicin—prostate cancer	0.000175	0.000678	CcSEcCtD
Bepridil—Arrhythmia—Prednisone—prostate cancer	0.000173	0.00067	CcSEcCtD
Bepridil—Palpitations—Docetaxel—prostate cancer	0.000172	0.000669	CcSEcCtD
Bepridil—Paraesthesia—Etoposide—prostate cancer	0.000172	0.000668	CcSEcCtD
Bepridil—Loss of consciousness—Docetaxel—prostate cancer	0.000171	0.000665	CcSEcCtD
Bepridil—Dyspnoea—Etoposide—prostate cancer	0.000171	0.000663	CcSEcCtD
Bepridil—Somnolence—Etoposide—prostate cancer	0.00017	0.000661	CcSEcCtD
Bepridil—Cough—Docetaxel—prostate cancer	0.00017	0.000661	CcSEcCtD
Bepridil—Angina pectoris—Doxorubicin—prostate cancer	0.00017	0.000661	CcSEcCtD
Bepridil—Vertigo—Capecitabine—prostate cancer	0.00017	0.000659	CcSEcCtD
Bepridil—Syncope—Capecitabine—prostate cancer	0.000169	0.000657	CcSEcCtD
Bepridil—Diarrhoea—Estradiol—prostate cancer	0.000169	0.000656	CcSEcCtD
Bepridil—Hypertension—Docetaxel—prostate cancer	0.000168	0.000654	CcSEcCtD
Bepridil—Drowsiness—Epirubicin—prostate cancer	0.000168	0.000654	CcSEcCtD
Bepridil—Palpitations—Capecitabine—prostate cancer	0.000167	0.000648	CcSEcCtD
Bepridil—Decreased appetite—Etoposide—prostate cancer	0.000166	0.000646	CcSEcCtD
Bepridil—Myalgia—Docetaxel—prostate cancer	0.000166	0.000645	CcSEcCtD
Bepridil—Loss of consciousness—Capecitabine—prostate cancer	0.000166	0.000644	CcSEcCtD
Bepridil—Gastrointestinal disorder—Etoposide—prostate cancer	0.000165	0.000642	CcSEcCtD
Bepridil—Asthenia—Mitoxantrone—prostate cancer	0.000165	0.000641	CcSEcCtD
Bepridil—Cough—Capecitabine—prostate cancer	0.000165	0.00064	CcSEcCtD
Bepridil—Pain—Etoposide—prostate cancer	0.000164	0.000636	CcSEcCtD
Bepridil—Constipation—Etoposide—prostate cancer	0.000164	0.000636	CcSEcCtD
Bepridil—Dizziness—Estradiol—prostate cancer	0.000163	0.000634	CcSEcCtD
Bepridil—Hypertension—Capecitabine—prostate cancer	0.000163	0.000633	CcSEcCtD
Bepridil—Dry mouth—Docetaxel—prostate cancer	0.000162	0.00063	CcSEcCtD
Bepridil—Sweating—Epirubicin—prostate cancer	0.000161	0.000627	CcSEcCtD
Bepridil—Myalgia—Capecitabine—prostate cancer	0.000161	0.000624	CcSEcCtD
Bepridil—Anxiety—Capecitabine—prostate cancer	0.00016	0.000622	CcSEcCtD
Bepridil—Oedema—Docetaxel—prostate cancer	0.000159	0.000618	CcSEcCtD
Bepridil—Vision blurred—Prednisone—prostate cancer	0.000159	0.000615	CcSEcCtD
Bepridil—Diarrhoea—Mitoxantrone—prostate cancer	0.000158	0.000612	CcSEcCtD
Bepridil—Dry mouth—Capecitabine—prostate cancer	0.000157	0.00061	CcSEcCtD
Bepridil—Gastrointestinal pain—Etoposide—prostate cancer	0.000157	0.000608	CcSEcCtD
Bepridil—Shock—Docetaxel—prostate cancer	0.000157	0.000608	CcSEcCtD
Bepridil—Rash—Estradiol—prostate cancer	0.000156	0.000605	CcSEcCtD
Bepridil—Drowsiness—Doxorubicin—prostate cancer	0.000156	0.000605	CcSEcCtD
Bepridil—Dermatitis—Estradiol—prostate cancer	0.000156	0.000604	CcSEcCtD
Bepridil—Headache—Estradiol—prostate cancer	0.000155	0.000601	CcSEcCtD
Bepridil—Oedema—Capecitabine—prostate cancer	0.000154	0.000598	CcSEcCtD
Bepridil—Bradycardia—Epirubicin—prostate cancer	0.000154	0.000597	CcSEcCtD
Bepridil—Anorexia—Docetaxel—prostate cancer	0.000152	0.000589	CcSEcCtD
Bepridil—Shock—Capecitabine—prostate cancer	0.000152	0.000589	CcSEcCtD
Bepridil—Rhinitis—Epirubicin—prostate cancer	0.000151	0.000588	CcSEcCtD
Bepridil—Body temperature increased—Etoposide—prostate cancer	0.000151	0.000588	CcSEcCtD
Bepridil—Abdominal pain—Etoposide—prostate cancer	0.000151	0.000588	CcSEcCtD
Bepridil—Vertigo—Prednisone—prostate cancer	0.000151	0.000587	CcSEcCtD
Bepridil—Syncope—Prednisone—prostate cancer	0.000151	0.000586	CcSEcCtD
Bepridil—Pharyngitis—Epirubicin—prostate cancer	0.00015	0.000582	CcSEcCtD
Bepridil—Sweating—Doxorubicin—prostate cancer	0.000149	0.00058	CcSEcCtD
Bepridil—Hyperhidrosis—Capecitabine—prostate cancer	0.000149	0.000578	CcSEcCtD
Bepridil—Loss of consciousness—Prednisone—prostate cancer	0.000148	0.000574	CcSEcCtD
Bepridil—Anorexia—Capecitabine—prostate cancer	0.000147	0.00057	CcSEcCtD
Bepridil—Nausea—Estradiol—prostate cancer	0.000147	0.00057	CcSEcCtD
Bepridil—Diphenhydramine—CYP2C19—prostate cancer	0.000147	0.0291	CrCbGaD
Bepridil—Hypertension—Prednisone—prostate cancer	0.000145	0.000564	CcSEcCtD
Bepridil—Rash—Mitoxantrone—prostate cancer	0.000145	0.000564	CcSEcCtD
Bepridil—Dermatitis—Mitoxantrone—prostate cancer	0.000145	0.000563	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Docetaxel—prostate cancer	0.000145	0.000563	CcSEcCtD
Bepridil—Headache—Mitoxantrone—prostate cancer	0.000144	0.00056	CcSEcCtD
Bepridil—Insomnia—Docetaxel—prostate cancer	0.000144	0.000559	CcSEcCtD
Bepridil—Myalgia—Prednisone—prostate cancer	0.000143	0.000556	CcSEcCtD
Bepridil—Paraesthesia—Docetaxel—prostate cancer	0.000143	0.000555	CcSEcCtD
Bepridil—Anxiety—Prednisone—prostate cancer	0.000143	0.000554	CcSEcCtD
Bepridil—Bradycardia—Doxorubicin—prostate cancer	0.000142	0.000553	CcSEcCtD
Bepridil—Dyspnoea—Docetaxel—prostate cancer	0.000142	0.000551	CcSEcCtD
Bepridil—Somnolence—Docetaxel—prostate cancer	0.000141	0.000549	CcSEcCtD
Bepridil—Tinnitus—Epirubicin—prostate cancer	0.000141	0.000547	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Capecitabine—prostate cancer	0.00014	0.000545	CcSEcCtD
Bepridil—Cardiac disorder—Epirubicin—prostate cancer	0.00014	0.000544	CcSEcCtD
Bepridil—Rhinitis—Doxorubicin—prostate cancer	0.00014	0.000544	CcSEcCtD
Bepridil—Dyspepsia—Docetaxel—prostate cancer	0.00014	0.000544	CcSEcCtD
Bepridil—Insomnia—Capecitabine—prostate cancer	0.000139	0.000541	CcSEcCtD
Bepridil—Pharyngitis—Doxorubicin—prostate cancer	0.000139	0.000539	CcSEcCtD
Bepridil—Paraesthesia—Capecitabine—prostate cancer	0.000138	0.000537	CcSEcCtD
Bepridil—Decreased appetite—Docetaxel—prostate cancer	0.000138	0.000537	CcSEcCtD
Bepridil—Gastrointestinal disorder—Docetaxel—prostate cancer	0.000137	0.000533	CcSEcCtD
Bepridil—Asthenia—Etoposide—prostate cancer	0.000137	0.000533	CcSEcCtD
Bepridil—Dyspnoea—Capecitabine—prostate cancer	0.000137	0.000533	CcSEcCtD
Bepridil—Oedema—Prednisone—prostate cancer	0.000137	0.000533	CcSEcCtD
Bepridil—Nausea—Mitoxantrone—prostate cancer	0.000137	0.000531	CcSEcCtD
Bepridil—Pain—Docetaxel—prostate cancer	0.000136	0.000528	CcSEcCtD
Bepridil—Constipation—Docetaxel—prostate cancer	0.000136	0.000528	CcSEcCtD
Bepridil—Dyspepsia—Capecitabine—prostate cancer	0.000136	0.000527	CcSEcCtD
Bepridil—Shock—Prednisone—prostate cancer	0.000135	0.000524	CcSEcCtD
Bepridil—Arrhythmia—Epirubicin—prostate cancer	0.000135	0.000524	CcSEcCtD
Bepridil—Decreased appetite—Capecitabine—prostate cancer	0.000134	0.00052	CcSEcCtD
Bepridil—Gastrointestinal disorder—Capecitabine—prostate cancer	0.000133	0.000517	CcSEcCtD
Bepridil—Hyperhidrosis—Prednisone—prostate cancer	0.000133	0.000515	CcSEcCtD
Bepridil—Dextropropoxyphene—CYP3A4—prostate cancer	0.000133	0.0264	CrCbGaD
Bepridil—Pain—Capecitabine—prostate cancer	0.000132	0.000512	CcSEcCtD
Bepridil—Constipation—Capecitabine—prostate cancer	0.000132	0.000512	CcSEcCtD
Bepridil—Fentanyl—CYP3A4—prostate cancer	0.000131	0.0261	CrCbGaD
Bepridil—Diarrhoea—Etoposide—prostate cancer	0.000131	0.000509	CcSEcCtD
Bepridil—Anorexia—Prednisone—prostate cancer	0.000131	0.000508	CcSEcCtD
Bepridil—Tinnitus—Doxorubicin—prostate cancer	0.00013	0.000506	CcSEcCtD
Bepridil—Gastrointestinal pain—Docetaxel—prostate cancer	0.00013	0.000505	CcSEcCtD
Bepridil—Cardiac disorder—Doxorubicin—prostate cancer	0.00013	0.000504	CcSEcCtD
Bepridil—Flatulence—Epirubicin—prostate cancer	0.00013	0.000503	CcSEcCtD
Bepridil—Tension—Epirubicin—prostate cancer	0.000129	0.000501	CcSEcCtD
Bepridil—Nervousness—Epirubicin—prostate cancer	0.000128	0.000496	CcSEcCtD
Bepridil—Dizziness—Etoposide—prostate cancer	0.000127	0.000492	CcSEcCtD
Bepridil—Gastrointestinal pain—Capecitabine—prostate cancer	0.000126	0.000489	CcSEcCtD
Bepridil—Abdominal pain—Docetaxel—prostate cancer	0.000126	0.000488	CcSEcCtD
Bepridil—Body temperature increased—Docetaxel—prostate cancer	0.000126	0.000488	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Prednisone—prostate cancer	0.000125	0.000486	CcSEcCtD
Bepridil—Arrhythmia—Doxorubicin—prostate cancer	0.000125	0.000485	CcSEcCtD
Bepridil—Insomnia—Prednisone—prostate cancer	0.000124	0.000482	CcSEcCtD
Bepridil—Vision blurred—Epirubicin—prostate cancer	0.000124	0.000481	CcSEcCtD
Bepridil—Paraesthesia—Prednisone—prostate cancer	0.000123	0.000479	CcSEcCtD
Bepridil—Body temperature increased—Capecitabine—prostate cancer	0.000122	0.000473	CcSEcCtD
Bepridil—Abdominal pain—Capecitabine—prostate cancer	0.000122	0.000473	CcSEcCtD
Bepridil—Dyspepsia—Prednisone—prostate cancer	0.000121	0.000469	CcSEcCtD
Bepridil—Rash—Etoposide—prostate cancer	0.000121	0.000469	CcSEcCtD
Bepridil—Dermatitis—Etoposide—prostate cancer	0.000121	0.000468	CcSEcCtD
Bepridil—Headache—Etoposide—prostate cancer	0.00012	0.000466	CcSEcCtD
Bepridil—Flatulence—Doxorubicin—prostate cancer	0.00012	0.000466	CcSEcCtD
Bepridil—Tension—Doxorubicin—prostate cancer	0.000119	0.000464	CcSEcCtD
Bepridil—Decreased appetite—Prednisone—prostate cancer	0.000119	0.000463	CcSEcCtD
Bepridil—Nervousness—Doxorubicin—prostate cancer	0.000118	0.000459	CcSEcCtD
Bepridil—Vertigo—Epirubicin—prostate cancer	0.000118	0.000459	CcSEcCtD
Bepridil—Syncope—Epirubicin—prostate cancer	0.000118	0.000458	CcSEcCtD
Bepridil—Constipation—Prednisone—prostate cancer	0.000117	0.000456	CcSEcCtD
Bepridil—Benzphetamine—CYP3A4—prostate cancer	0.000116	0.0231	CrCbGaD
Bepridil—Palpitations—Epirubicin—prostate cancer	0.000116	0.000451	CcSEcCtD
Bepridil—Loss of consciousness—Epirubicin—prostate cancer	0.000116	0.000449	CcSEcCtD
Bepridil—Cough—Epirubicin—prostate cancer	0.000115	0.000446	CcSEcCtD
Bepridil—Vision blurred—Doxorubicin—prostate cancer	0.000115	0.000445	CcSEcCtD
Bepridil—Asthenia—Docetaxel—prostate cancer	0.000114	0.000443	CcSEcCtD
Bepridil—Nausea—Etoposide—prostate cancer	0.000114	0.000442	CcSEcCtD
Bepridil—Hypertension—Epirubicin—prostate cancer	0.000114	0.000441	CcSEcCtD
Bepridil—Gastrointestinal pain—Prednisone—prostate cancer	0.000112	0.000436	CcSEcCtD
Bepridil—Myalgia—Epirubicin—prostate cancer	0.000112	0.000435	CcSEcCtD
Bepridil—Anxiety—Epirubicin—prostate cancer	0.000112	0.000433	CcSEcCtD
Bepridil—Phenoxybenzamine—CYP3A4—prostate cancer	0.000111	0.0221	CrCbGaD
Bepridil—Asthenia—Capecitabine—prostate cancer	0.000111	0.000429	CcSEcCtD
Bepridil—Dry mouth—Epirubicin—prostate cancer	0.00011	0.000425	CcSEcCtD
Bepridil—Vertigo—Doxorubicin—prostate cancer	0.000109	0.000425	CcSEcCtD
Bepridil—Syncope—Doxorubicin—prostate cancer	0.000109	0.000424	CcSEcCtD
Bepridil—Diarrhoea—Docetaxel—prostate cancer	0.000109	0.000423	CcSEcCtD
Bepridil—Abdominal pain—Prednisone—prostate cancer	0.000109	0.000421	CcSEcCtD
Bepridil—Body temperature increased—Prednisone—prostate cancer	0.000109	0.000421	CcSEcCtD
Bepridil—Palpitations—Doxorubicin—prostate cancer	0.000108	0.000418	CcSEcCtD
Bepridil—Oedema—Epirubicin—prostate cancer	0.000107	0.000417	CcSEcCtD
Bepridil—Loss of consciousness—Doxorubicin—prostate cancer	0.000107	0.000415	CcSEcCtD
Bepridil—Cough—Doxorubicin—prostate cancer	0.000106	0.000412	CcSEcCtD
Bepridil—Shock—Epirubicin—prostate cancer	0.000106	0.00041	CcSEcCtD
Bepridil—Diarrhoea—Capecitabine—prostate cancer	0.000105	0.000409	CcSEcCtD
Bepridil—Dizziness—Docetaxel—prostate cancer	0.000105	0.000409	CcSEcCtD
Bepridil—Hypertension—Doxorubicin—prostate cancer	0.000105	0.000408	CcSEcCtD
Bepridil—Hyperhidrosis—Epirubicin—prostate cancer	0.000104	0.000403	CcSEcCtD
Bepridil—Myalgia—Doxorubicin—prostate cancer	0.000104	0.000402	CcSEcCtD
Bepridil—Anxiety—Doxorubicin—prostate cancer	0.000103	0.000401	CcSEcCtD
Bepridil—Anorexia—Epirubicin—prostate cancer	0.000102	0.000397	CcSEcCtD
Bepridil—Dizziness—Capecitabine—prostate cancer	0.000102	0.000396	CcSEcCtD
Bepridil—Dry mouth—Doxorubicin—prostate cancer	0.000101	0.000393	CcSEcCtD
Bepridil—Rash—Docetaxel—prostate cancer	0.0001	0.00039	CcSEcCtD
Bepridil—Dermatitis—Docetaxel—prostate cancer	0.0001	0.000389	CcSEcCtD
Bepridil—Headache—Docetaxel—prostate cancer	9.97e-05	0.000387	CcSEcCtD
Bepridil—Oedema—Doxorubicin—prostate cancer	9.93e-05	0.000386	CcSEcCtD
Bepridil—Asthenia—Prednisone—prostate cancer	9.85e-05	0.000382	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Epirubicin—prostate cancer	9.78e-05	0.00038	CcSEcCtD
Bepridil—Shock—Doxorubicin—prostate cancer	9.77e-05	0.000379	CcSEcCtD
Bepridil—Rash—Capecitabine—prostate cancer	9.72e-05	0.000377	CcSEcCtD
Bepridil—Insomnia—Epirubicin—prostate cancer	9.71e-05	0.000377	CcSEcCtD
Bepridil—Dermatitis—Capecitabine—prostate cancer	9.71e-05	0.000377	CcSEcCtD
Bepridil—Headache—Capecitabine—prostate cancer	9.65e-05	0.000375	CcSEcCtD
Bepridil—Paraesthesia—Epirubicin—prostate cancer	9.64e-05	0.000374	CcSEcCtD
Bepridil—Hyperhidrosis—Doxorubicin—prostate cancer	9.6e-05	0.000373	CcSEcCtD
Bepridil—Dyspnoea—Epirubicin—prostate cancer	9.57e-05	0.000372	CcSEcCtD
Bepridil—Somnolence—Epirubicin—prostate cancer	9.54e-05	0.000371	CcSEcCtD
Bepridil—Anorexia—Doxorubicin—prostate cancer	9.47e-05	0.000368	CcSEcCtD
Bepridil—Nausea—Docetaxel—prostate cancer	9.45e-05	0.000367	CcSEcCtD
Bepridil—Dyspepsia—Epirubicin—prostate cancer	9.45e-05	0.000367	CcSEcCtD
Bepridil—Diarrhoea—Prednisone—prostate cancer	9.39e-05	0.000365	CcSEcCtD
Bepridil—Decreased appetite—Epirubicin—prostate cancer	9.33e-05	0.000362	CcSEcCtD
Bepridil—Gastrointestinal disorder—Epirubicin—prostate cancer	9.27e-05	0.00036	CcSEcCtD
Bepridil—Pain—Epirubicin—prostate cancer	9.18e-05	0.000356	CcSEcCtD
Bepridil—Constipation—Epirubicin—prostate cancer	9.18e-05	0.000356	CcSEcCtD
Bepridil—Nausea—Capecitabine—prostate cancer	9.15e-05	0.000355	CcSEcCtD
Bepridil—Dizziness—Prednisone—prostate cancer	9.08e-05	0.000352	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Doxorubicin—prostate cancer	9.05e-05	0.000351	CcSEcCtD
Bepridil—Insomnia—Doxorubicin—prostate cancer	8.98e-05	0.000349	CcSEcCtD
Bepridil—Paraesthesia—Doxorubicin—prostate cancer	8.92e-05	0.000346	CcSEcCtD
Bepridil—Dyspnoea—Doxorubicin—prostate cancer	8.86e-05	0.000344	CcSEcCtD
Bepridil—Somnolence—Doxorubicin—prostate cancer	8.83e-05	0.000343	CcSEcCtD
Bepridil—Gastrointestinal pain—Epirubicin—prostate cancer	8.78e-05	0.000341	CcSEcCtD
Bepridil—Dyspepsia—Doxorubicin—prostate cancer	8.74e-05	0.000339	CcSEcCtD
Bepridil—Rash—Prednisone—prostate cancer	8.65e-05	0.000336	CcSEcCtD
Bepridil—Dermatitis—Prednisone—prostate cancer	8.65e-05	0.000336	CcSEcCtD
Bepridil—Decreased appetite—Doxorubicin—prostate cancer	8.64e-05	0.000335	CcSEcCtD
Bepridil—Headache—Prednisone—prostate cancer	8.6e-05	0.000334	CcSEcCtD
Bepridil—Gastrointestinal disorder—Doxorubicin—prostate cancer	8.58e-05	0.000333	CcSEcCtD
Bepridil—Constipation—Doxorubicin—prostate cancer	8.49e-05	0.00033	CcSEcCtD
Bepridil—Pain—Doxorubicin—prostate cancer	8.49e-05	0.00033	CcSEcCtD
Bepridil—Abdominal pain—Epirubicin—prostate cancer	8.49e-05	0.000329	CcSEcCtD
Bepridil—Body temperature increased—Epirubicin—prostate cancer	8.49e-05	0.000329	CcSEcCtD
Bepridil—Nausea—Prednisone—prostate cancer	8.15e-05	0.000317	CcSEcCtD
Bepridil—Gastrointestinal pain—Doxorubicin—prostate cancer	8.12e-05	0.000315	CcSEcCtD
Bepridil—Body temperature increased—Doxorubicin—prostate cancer	7.85e-05	0.000305	CcSEcCtD
Bepridil—Abdominal pain—Doxorubicin—prostate cancer	7.85e-05	0.000305	CcSEcCtD
Bepridil—Asthenia—Epirubicin—prostate cancer	7.7e-05	0.000299	CcSEcCtD
Bepridil—Diarrhoea—Epirubicin—prostate cancer	7.35e-05	0.000285	CcSEcCtD
Bepridil—Asthenia—Doxorubicin—prostate cancer	7.13e-05	0.000277	CcSEcCtD
Bepridil—Dizziness—Epirubicin—prostate cancer	7.1e-05	0.000276	CcSEcCtD
Bepridil—Diarrhoea—Doxorubicin—prostate cancer	6.8e-05	0.000264	CcSEcCtD
Bepridil—Rash—Epirubicin—prostate cancer	6.77e-05	0.000263	CcSEcCtD
Bepridil—Dermatitis—Epirubicin—prostate cancer	6.76e-05	0.000263	CcSEcCtD
Bepridil—Headache—Epirubicin—prostate cancer	6.73e-05	0.000261	CcSEcCtD
Bepridil—Dizziness—Doxorubicin—prostate cancer	6.57e-05	0.000255	CcSEcCtD
Bepridil—Nausea—Epirubicin—prostate cancer	6.38e-05	0.000248	CcSEcCtD
Bepridil—Rash—Doxorubicin—prostate cancer	6.26e-05	0.000243	CcSEcCtD
Bepridil—Dermatitis—Doxorubicin—prostate cancer	6.26e-05	0.000243	CcSEcCtD
Bepridil—Headache—Doxorubicin—prostate cancer	6.22e-05	0.000242	CcSEcCtD
Bepridil—Nausea—Doxorubicin—prostate cancer	5.9e-05	0.000229	CcSEcCtD
Bepridil—CALM2—Signaling Pathways—BAD—prostate cancer	2.41e-06	8.31e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—BAD—prostate cancer	2.41e-06	8.31e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PPARA—prostate cancer	2.4e-06	8.29e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CAV1—prostate cancer	2.4e-06	8.28e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—CDKN1B—prostate cancer	2.39e-06	8.26e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—CDKN1B—prostate cancer	2.39e-06	8.26e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—CDKN1A—prostate cancer	2.39e-06	8.26e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—CDKN1A—prostate cancer	2.39e-06	8.26e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—NOS3—prostate cancer	2.39e-06	8.26e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—PTEN—prostate cancer	2.39e-06	8.24e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—PTEN—prostate cancer	2.39e-06	8.24e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGF—prostate cancer	2.38e-06	8.22e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IRS1—prostate cancer	2.38e-06	8.22e-06	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—AKT1—prostate cancer	2.36e-06	8.15e-06	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—AKT1—prostate cancer	2.36e-06	8.15e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—EP300—prostate cancer	2.35e-06	8.12e-06	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—AKT1—prostate cancer	2.34e-06	8.09e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—CTNNB1—prostate cancer	2.34e-06	8.07e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APC—prostate cancer	2.33e-06	8.05e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CG—prostate cancer	2.33e-06	8.05e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CG—prostate cancer	2.33e-06	8.05e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APC—prostate cancer	2.33e-06	8.05e-06	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AKT1—prostate cancer	2.32e-06	8e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—NOS3—prostate cancer	2.31e-06	7.99e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—NOS3—prostate cancer	2.31e-06	7.99e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—GSK3B—prostate cancer	2.31e-06	7.98e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGF—prostate cancer	2.3e-06	7.95e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IRS1—prostate cancer	2.3e-06	7.95e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IRS1—prostate cancer	2.3e-06	7.95e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGF—prostate cancer	2.3e-06	7.95e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—SRC—prostate cancer	2.29e-06	7.9e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—CDKN1A—prostate cancer	2.28e-06	7.88e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—INS—prostate cancer	2.28e-06	7.87e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—PTEN—prostate cancer	2.28e-06	7.86e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—EP300—prostate cancer	2.28e-06	7.86e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—EP300—prostate cancer	2.28e-06	7.86e-06	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—AKT1—prostate cancer	2.27e-06	7.83e-06	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—AKT1—prostate cancer	2.27e-06	7.83e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—CTNNB1—prostate cancer	2.26e-06	7.8e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—CTNNB1—prostate cancer	2.26e-06	7.8e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CAV1—prostate cancer	2.26e-06	7.8e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—GSK3B—prostate cancer	2.24e-06	7.72e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—GSK3B—prostate cancer	2.24e-06	7.72e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CREBBP—prostate cancer	2.23e-06	7.71e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—SRC—prostate cancer	2.21e-06	7.64e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—SRC—prostate cancer	2.21e-06	7.64e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—CDKN1A—prostate cancer	2.21e-06	7.62e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—CDKN1A—prostate cancer	2.21e-06	7.62e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CB—prostate cancer	2.21e-06	7.62e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—STAT3—prostate cancer	2.21e-06	7.62e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—INS—prostate cancer	2.21e-06	7.62e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—INS—prostate cancer	2.21e-06	7.62e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1—prostate cancer	2.2e-06	7.61e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—PTEN—prostate cancer	2.2e-06	7.61e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—PTEN—prostate cancer	2.2e-06	7.61e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—prostate cancer	2.19e-06	7.58e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—prostate cancer	2.19e-06	7.55e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CG—prostate cancer	2.18e-06	7.54e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—EP300—prostate cancer	2.17e-06	7.5e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CREBBP—prostate cancer	2.16e-06	7.46e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CREBBP—prostate cancer	2.16e-06	7.46e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CB—prostate cancer	2.13e-06	7.37e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CB—prostate cancer	2.13e-06	7.37e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—STAT3—prostate cancer	2.13e-06	7.37e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—STAT3—prostate cancer	2.13e-06	7.37e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1—prostate cancer	2.13e-06	7.37e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1—prostate cancer	2.13e-06	7.37e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAP2K1—prostate cancer	2.13e-06	7.36e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—prostate cancer	2.12e-06	7.33e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—prostate cancer	2.12e-06	7.33e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CD—prostate cancer	2.12e-06	7.31e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—prostate cancer	2.12e-06	7.3e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—prostate cancer	2.12e-06	7.3e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—SRC—prostate cancer	2.11e-06	7.29e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—EP300—prostate cancer	2.1e-06	7.25e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—EP300—prostate cancer	2.1e-06	7.25e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SERPINE1—prostate cancer	2.09e-06	7.23e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—KRAS—prostate cancer	2.07e-06	7.16e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—INS—prostate cancer	2.07e-06	7.14e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAP2K1—prostate cancer	2.06e-06	7.12e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAP2K1—prostate cancer	2.06e-06	7.12e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.06e-06	7.1e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CD—prostate cancer	2.05e-06	7.07e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CD—prostate cancer	2.05e-06	7.07e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—SRC—prostate cancer	2.04e-06	7.05e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—SRC—prostate cancer	2.04e-06	7.05e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—STAT3—prostate cancer	2.04e-06	7.03e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FGF2—prostate cancer	2.03e-06	7e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SERPINE1—prostate cancer	2.03e-06	7e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SERPINE1—prostate cancer	2.03e-06	7e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CREBBP—prostate cancer	2.02e-06	6.99e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—KRAS—prostate cancer	2e-06	6.92e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—KRAS—prostate cancer	2e-06	6.92e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—prostate cancer	2e-06	6.92e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NOS3—prostate cancer	2e-06	6.9e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—STAT3—prostate cancer	1.97e-06	6.8e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—STAT3—prostate cancer	1.97e-06	6.8e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FGF2—prostate cancer	1.96e-06	6.77e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FGF2—prostate cancer	1.96e-06	6.77e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—INS—prostate cancer	1.95e-06	6.72e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—JAK2—prostate cancer	1.94e-06	6.71e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—prostate cancer	1.94e-06	6.7e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—prostate cancer	1.94e-06	6.7e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NOS3—prostate cancer	1.93e-06	6.68e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NOS3—prostate cancer	1.93e-06	6.68e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CD—prostate cancer	1.92e-06	6.63e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CREBBP—prostate cancer	1.91e-06	6.59e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTEN—prostate cancer	1.91e-06	6.59e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—PIK3CA—prostate cancer	1.9e-06	6.58e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MDM2—prostate cancer	1.9e-06	6.55e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—KRAS—prostate cancer	1.89e-06	6.54e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—MYC—prostate cancer	1.89e-06	6.54e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFB1—prostate cancer	1.89e-06	6.52e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—JAK2—prostate cancer	1.88e-06	6.49e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—JAK2—prostate cancer	1.88e-06	6.49e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ERBB2—prostate cancer	1.87e-06	6.46e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—prostate cancer	1.85e-06	6.39e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CB—prostate cancer	1.85e-06	6.37e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTEN—prostate cancer	1.84e-06	6.37e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTEN—prostate cancer	1.84e-06	6.37e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—PIK3CA—prostate cancer	1.84e-06	6.36e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—PIK3CA—prostate cancer	1.84e-06	6.36e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MDM2—prostate cancer	1.83e-06	6.34e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MDM2—prostate cancer	1.83e-06	6.34e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—KRAS—prostate cancer	1.83e-06	6.33e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—KRAS—prostate cancer	1.83e-06	6.33e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—MYC—prostate cancer	1.83e-06	6.32e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—MYC—prostate cancer	1.83e-06	6.32e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFB1—prostate cancer	1.83e-06	6.31e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFB1—prostate cancer	1.83e-06	6.31e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—EP300—prostate cancer	1.82e-06	6.28e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—NOS3—prostate cancer	1.81e-06	6.26e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ERBB2—prostate cancer	1.81e-06	6.25e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ERBB2—prostate cancer	1.81e-06	6.25e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.81e-06	6.24e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—prostate cancer	1.79e-06	6.18e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—prostate cancer	1.79e-06	6.18e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CB—prostate cancer	1.79e-06	6.16e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CB—prostate cancer	1.79e-06	6.16e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCL8—prostate cancer	1.77e-06	6.12e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—EP300—prostate cancer	1.76e-06	6.08e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—EP300—prostate cancer	1.76e-06	6.08e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—KRAS—prostate cancer	1.75e-06	6.04e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—PIK3CA—prostate cancer	1.74e-06	6.01e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CDKN1B—prostate cancer	1.73e-06	5.98e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCL8—prostate cancer	1.72e-06	5.92e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCL8—prostate cancer	1.72e-06	5.92e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—NOS3—prostate cancer	1.71e-06	5.9e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CASP3—prostate cancer	1.7e-06	5.86e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL2—prostate cancer	1.69e-06	5.85e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—KRAS—prostate cancer	1.69e-06	5.84e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—KRAS—prostate cancer	1.69e-06	5.84e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—prostate cancer	1.69e-06	5.82e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—PIK3CA—prostate cancer	1.68e-06	5.81e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—PIK3CA—prostate cancer	1.68e-06	5.81e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CDKN1B—prostate cancer	1.68e-06	5.79e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CDKN1B—prostate cancer	1.68e-06	5.79e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CB—prostate cancer	1.67e-06	5.78e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—prostate cancer	1.66e-06	5.72e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCND1—prostate cancer	1.65e-06	5.71e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CASP3—prostate cancer	1.64e-06	5.67e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CASP3—prostate cancer	1.64e-06	5.67e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL2—prostate cancer	1.64e-06	5.66e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL2—prostate cancer	1.64e-06	5.66e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CTNNB1—prostate cancer	1.64e-06	5.65e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—prostate cancer	1.63e-06	5.63e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—prostate cancer	1.63e-06	5.63e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—PIK3CA—prostate cancer	1.61e-06	5.55e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP9—prostate cancer	1.6e-06	5.54e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CDKN1A—prostate cancer	1.6e-06	5.52e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCND1—prostate cancer	1.6e-06	5.52e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCND1—prostate cancer	1.6e-06	5.52e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PTEN—prostate cancer	1.59e-06	5.51e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CTNNB1—prostate cancer	1.58e-06	5.47e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CTNNB1—prostate cancer	1.58e-06	5.47e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.58e-06	5.44e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—prostate cancer	1.56e-06	5.39e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AKT1—prostate cancer	1.56e-06	5.37e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—PIK3CA—prostate cancer	1.55e-06	5.37e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—PIK3CA—prostate cancer	1.55e-06	5.37e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP9—prostate cancer	1.55e-06	5.36e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP9—prostate cancer	1.55e-06	5.36e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CDKN1A—prostate cancer	1.55e-06	5.34e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CDKN1A—prostate cancer	1.55e-06	5.34e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PTEN—prostate cancer	1.54e-06	5.33e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PTEN—prostate cancer	1.54e-06	5.33e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—prostate cancer	1.54e-06	5.32e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EP300—prostate cancer	1.52e-06	5.25e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AKT1—prostate cancer	1.5e-06	5.2e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AKT1—prostate cancer	1.5e-06	5.2e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—prostate cancer	1.49e-06	5.15e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—prostate cancer	1.49e-06	5.15e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SRC—prostate cancer	1.48e-06	5.11e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EP300—prostate cancer	1.47e-06	5.08e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EP300—prostate cancer	1.47e-06	5.08e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTEN—prostate cancer	1.45e-06	4.99e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—prostate cancer	1.44e-06	4.97e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SRC—prostate cancer	1.43e-06	4.94e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SRC—prostate cancer	1.43e-06	4.94e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—STAT3—prostate cancer	1.43e-06	4.92e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—prostate cancer	1.42e-06	4.91e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—AKT1—prostate cancer	1.42e-06	4.91e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—prostate cancer	1.39e-06	4.81e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—prostate cancer	1.39e-06	4.81e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—STAT3—prostate cancer	1.38e-06	4.76e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—STAT3—prostate cancer	1.38e-06	4.76e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—EP300—prostate cancer	1.38e-06	4.76e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—prostate cancer	1.38e-06	4.75e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—prostate cancer	1.38e-06	4.75e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—AKT1—prostate cancer	1.37e-06	4.75e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—AKT1—prostate cancer	1.37e-06	4.75e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTEN—prostate cancer	1.36e-06	4.7e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CA—prostate cancer	1.35e-06	4.65e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MYC—prostate cancer	1.33e-06	4.58e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFB1—prostate cancer	1.32e-06	4.57e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT1—prostate cancer	1.31e-06	4.53e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CA—prostate cancer	1.3e-06	4.49e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CA—prostate cancer	1.3e-06	4.49e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—EP300—prostate cancer	1.3e-06	4.49e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—prostate cancer	1.3e-06	4.48e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MYC—prostate cancer	1.28e-06	4.43e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MYC—prostate cancer	1.28e-06	4.43e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFB1—prostate cancer	1.28e-06	4.42e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFB1—prostate cancer	1.28e-06	4.42e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT1—prostate cancer	1.27e-06	4.38e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT1—prostate cancer	1.27e-06	4.38e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—prostate cancer	1.25e-06	4.33e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—prostate cancer	1.25e-06	4.33e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KRAS—prostate cancer	1.22e-06	4.23e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KRAS—prostate cancer	1.18e-06	4.09e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KRAS—prostate cancer	1.18e-06	4.09e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CA—prostate cancer	1.12e-06	3.88e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AKT1—prostate cancer	1.1e-06	3.8e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—prostate cancer	1.09e-06	3.76e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CA—prostate cancer	1.09e-06	3.76e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CA—prostate cancer	1.09e-06	3.76e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AKT1—prostate cancer	1.06e-06	3.67e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AKT1—prostate cancer	1.06e-06	3.67e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—prostate cancer	1.05e-06	3.64e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—prostate cancer	1.05e-06	3.64e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CA—prostate cancer	1.02e-06	3.52e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—prostate cancer	9.96e-07	3.44e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—prostate cancer	9.64e-07	3.33e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—prostate cancer	9.64e-07	3.33e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CA—prostate cancer	9.61e-07	3.32e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT1—prostate cancer	9.19e-07	3.17e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT1—prostate cancer	8.89e-07	3.07e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT1—prostate cancer	8.89e-07	3.07e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AKT1—prostate cancer	8.33e-07	2.88e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKT1—prostate cancer	7.85e-07	2.71e-06	CbGpPWpGaD
